Sramana Mitra: My conclusion, to some extent, is that the drive to get these kinds of systems out would probably need to come from the payers because they are incentivized to keep people healthy. You’re right. The data are sitting inside of different providers. It’s a complex adoption cycle. In your orbit, who are at
Sramana Mitra: If you were starting a company today, how would you frame that? Given those trends and those dynamics, how would you frame an opportunity? Michael O’Neil: This notion of precision medicine is all the rage in healthcare today. It’s about finding very precise therapies – devices, pills, diagnostics – that go directly to
There are tremendous inefficiencies in the healthcare ecosystem and a large percentage of these can be streamlined with technology. This is a field where technology has an unambiguous positive impact to bring to bear. However, we’re still far from where we need to be. Sramana Mitra: Let’s start with some introduction. Let’s introduce our audience